Background Intestinal schistosomiasis continues to be a significant cause of morbidity among
communities located around Lake Victoria and on its islands. Although epidemiological …

Schistosomiasis is among the most common parasitic diseases in the world, with over 142
million people infected in low- and middle-income countries. Measuring population-level …

Background Identification of populations to be targeted for individual treatment and broad-spectrum
therapy in schistosomiasis-endemic areas, assessment of therapy efficacy, morbidity…

Background Evidence indicates that whereas repeated rounds of mass drug administration (MDA)
programs have reduced schistosomiasis prevalence to appreciable levels in some …

Background Persistent hotspots have been described after mass drug administration (MDA)
for the control of schistosomiasis, but they have not been studied during the course of a …

Background Reliance on praziquantel for treatment and control of schistosomiasis is likely
to facilitate the emergence of drug resistance. Combination therapy targeting adult and …

Background WHO has underlined the need for a child-friendly treatment for schistosomiasis,
a prevalent parasitic disease in low-income and middle-income countries. After successful …

Few B cells express CD27, the primary marker for memory B cells, in pediatric schistosomiasis,
suggesting B cell malfunction. This study further demonstrates unexpected high …

Background Socioeconomic inequality including wealth distribution is a barrier to implementation
of health policies. Wealth distribution can be measured effectively using household …

Background Control and elimination of schistosomiasis is an arduous task, with current
strategies proving inadequate to break transmission. Exploration of genetic approaches to …